Musclin Mitigates the Attachment of HUVECs to THP-1 Monocytes in Hyperlipidemic Conditions through PPARα/HO-1-Mediated Attenuation of Inflammation.

[1]  J. Jeong,et al.  Musclin attenuates lipid deposition in hepatocytes through SIRT7/autophagy-mediated suppression of ER stress. , 2023, Biochemical and biophysical research communications.

[2]  J. Jeong,et al.  Myokine musclin alleviates lipid accumulation in 3T3-L1 adipocytes through PKA/p38-mediated upregulation of lipolysis and suppression of lipogenesis. , 2022, Biochemical and biophysical research communications.

[3]  N. Mochizuki,et al.  Osteocrin ameliorates adriamycin nephropathy via p38 mitogen-activated protein kinase inhibition , 2021, Scientific Reports.

[4]  M. Yepes-Calderón,et al.  Efficacy of high-intensity interval- or continuous aerobic-training on insulin resistance and muscle function in adults with metabolic syndrome: a clinical trial , 2021, European Journal of Applied Physiology.

[5]  C. Meisinger,et al.  Simulating the dynamics of atherosclerosis to the incidence of myocardial infarction, applied to the KORA population , 2021, Statistics in medicine.

[6]  P. Libby,et al.  Targeting inflammation in atherosclerosis — from experimental insights to the clinic , 2021, Nature Reviews Drug Discovery.

[7]  M. Iemitsu,et al.  Decreased muscle‐derived musclin by chronic resistance exercise is associated with improved insulin resistance in rats with type 2 diabetes , 2021, Physiological reports.

[8]  Q. Tang,et al.  Osteocrin attenuates inflammation, oxidative stress, apoptosis, and cardiac dysfunction in doxorubicin‐induced cardiotoxicity , 2020, Clinical and translational medicine.

[9]  A. A. Abd El-Aty,et al.  Clinically confirmed DEL-1 as a myokine attenuates lipid-induced inflammation and insulin resistance in 3T3-L1 adipocytes via AMPK/HO-1- pathway , 2020, Adipocyte.

[10]  A. Hoofnagle,et al.  Obesity and Insulin Resistance Promote Atherosclerosis through an IFNγ-Regulated Macrophage Protein Network , 2018, Cell reports.

[11]  B. Li,et al.  Overexpression of Heme Oxygenase-1 Prevents Renal Interstitial Inflammation and Fibrosis Induced by Unilateral Ureter Obstruction , 2016, PloS one.

[12]  S. Reyes,et al.  Musclin is an activity-stimulated myokine that enhances physical endurance , 2015, Proceedings of the National Academy of Sciences.

[13]  Philippe Lefebvre,et al.  Molecular mechanism of PPARα action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease. , 2015, Journal of hepatology.

[14]  Hongli Li,et al.  Role of peroxisome proliferator-activated receptor α in atherosclerosis. , 2014, Molecular medicine reports.

[15]  Yingxiao Li,et al.  Role of Musclin in the Pathogenesis of Hypertension in Rat , 2013, PloS one.

[16]  S. Anker,et al.  Overweight and obesity are associated with improved survival, functional outcome, and stroke recurrence after acute stroke or transient ischaemic attack: observations from the TEMPiS trial. , 2013, European heart journal.

[17]  Min Zhang,et al.  Heme Oxygenase-1, Oxidation, Inflammation, and Atherosclerosis , 2012, Front. Pharmacol..

[18]  C. Glass,et al.  PPARs and lipid ligands in inflammation and metabolism. , 2011, Chemical reviews.

[19]  W. Durante.  Protective role of heme oxygenase-1 against inflammation in atherosclerosis. , 2011, Frontiers in bioscience.

[20]  K. Chang,et al.  Role of heme oxygenase in preserving vascular bioactive NO. , 2010, Nitric oxide : biology and chemistry.

[21]  G. H. Thoresen,et al.  The Role of PPARα Activation in Liver and Muscle , 2010, PPAR research.

[22]  Z. Zong,et al.  Musclin Inhibits Insulin Activation of Akt/Protein Kinase B in Rat Skeletal Muscle , 2008, The Journal of international medical research.

[23]  N. Abraham,et al.  Heme oxygenase: a target gene for anti-diabetic and obesity. , 2008, Current pharmaceutical design.

[24]  G. Sangiorgi,et al.  Role of Inflammation in Atherosclerosis* , 2007, Journal of Nuclear Medicine.

[25]  F. Hu,et al.  Association of overweight with increased risk of coronary heart disease partly independent of blood pressure and cholesterol levels: a meta-analysis of 21 cohort studies including more than 300 000 persons. , 2007, Archives of internal medicine.

[26]  J. Plutzky,et al.  PPARα in atherosclerosis and inflammation , 2007 .

[27]  N. Sibinga,et al.  Absence of heme oxygenase‐1 exacerbates atherosclerotic lesion formation and vascular remodeling , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[28]  D. Rader,et al.  Lipolysis of triglyceride-rich lipoproteins generates PPAR ligands: Evidence for an antiinflammatory role for lipoprotein lipase , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[29]  A. Beaudet,et al.  P-Selectin or Intercellular Adhesion Molecule (Icam)-1 Deficiency Substantially Protects against Atherosclerosis in Apolipoprotein E–Deficient Mice , 2000, The Journal of experimental medicine.